Security Snapshot

Dolby Laboratories, Inc. - Class A Common Stock (DLB) Institutional Ownership

CUSIP: 25659T107

13F Institutional Holders and Ownership History from Q1 2014 to Q1 2026

Latest Period

Q1 2026

Institutions Reporting

411

Shares (Excl. Options)

58,387,638

Price

$60.06

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Type / Class
Equity / Class A Common Stock
Symbol
DLB on NYSE
Shares outstanding
61,228,988
Price per share
$63.26
All holders as of 31 Mar 2026
Q1 2026
Total 13F shares
58,387,638
Total reported value
$3,505,571,671
% of total 13F portfolios
0%
Share change
-664,278
Value change
-$49,940,846
Number of holders
411
Price from insider filings
$63.26
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Quick Takeaways

  • DLB - Dolby Laboratories, Inc. - Class A Common Stock is tracked under CUSIP 25659T107.
  • 411 institutions reported positions in Q1 2026.
  • 4 significant owners is listed from Schedule 13D/13G reporting.

What Changed

  • Holder count moved from 401 to 411 between Q4 2025 and Q1 2026.
  • Reported value moved from $3,767,152,036 to $3,505,571,671.

Why This Matters

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Source Evidence

Source: SEC Form 13F

Latest holder context comes from 411 institutions filings for Q1 2026.

Open SEC Evidence

Investment Quick Answers

What is CUSIP 25659T107?
CUSIP 25659T107 identifies DLB - Dolby Laboratories, Inc. - Class A Common Stock in SEC 13F datasets.

Where can I see the latest institutional holders?
Review the Q1 2026 holders report and the ownership history table below.

Significant Owners of Dolby Laboratories, Inc. - Class A Common Stock (DLB) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Dolby Dagmar 36% -1.6% $2,207,135,951 -$59,949,370 34,368,358 -2.6% Dagmar Dolby 11 Feb 2026
VANGUARD GROUP INC 12% $571,132,370 7,535,722 The Vanguard Group 31 Mar 2025
MORGAN STANLEY 8.2% -20% $309,079,032 -$72,115,324 5,020,777 -19% Morgan Stanley 31 Mar 2026
Bank of New York Mellon Corp 7.4% -21% $270,259,189 -$72,634,942 4,499,820 -21% Bank of New York Mellon Corp 31 Mar 2026

As of 31 Mar 2026, 411 institutional investors reported holding 58,387,638 shares of Dolby Laboratories, Inc. - Class A Common Stock (DLB). This represents 95% of the company’s total 61,228,988 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Dolby Laboratories, Inc. - Class A Common Stock (DLB) together control 73% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
BlackRock, Inc. 11% 6,538,336 +7.2% 0.01% $392,692,443
MORGAN STANLEY 8.4% 5,142,168 -17% 0.02% $308,838,741
VANGUARD PORTFOLIO MANAGEMENT LLC 8.1% 4,970,824 0% 0.02% $298,547,689
Bank of New York Mellon Corp 7.3% 4,499,820 -14% 0.05% $270,259,193
VANGUARD CAPITAL MANAGEMENT LLC 4.5% 2,726,375 0% 0% $163,746,083
STATE STREET CORP 3.7% 2,290,579 +2.2% 0% $137,572,175
FIRST TRUST ADVISORS LP 3.7% 2,254,933 +20% 0.1% $135,431,169
GEODE CAPITAL MANAGEMENT, LLC 2.9% 1,765,109 -6.4% 0.01% $106,029,501
ACADIAN ASSET MANAGEMENT LLC 2.6% 1,571,374 +34% 0.13% $94,347,000
SNYDER CAPITAL MANAGEMENT L P 2.2% 1,361,448 -4.6% 1.6% $81,768,567
DIMENSIONAL FUND ADVISORS LP 2.2% 1,321,407 +6.8% 0.02% $79,356,614
DISCIPLINED GROWTH INVESTORS INC /MN 2.1% 1,267,783 -5.6% 1.6% $76,143,047
GOLDMAN SACHS GROUP INC 1.9% 1,180,311 +17% 0.01% $70,889,493
MACKENZIE FINANCIAL CORP 1.9% 1,167,121 +0.27% 0.08% $70,097,287
AQR CAPITAL MANAGEMENT LLC 1.8% 1,112,460 +32% 0.03% $65,590,650
FMR LLC 1.7% 1,012,520 +5812% 0% $60,811,989
Fiera Capital Corp 1.4% 834,188 +2.7% 0.17% $50,101,332
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 1.3% 804,240 +7% 0.01% $48,302,654
NORTHERN TRUST CORP 0.87% 532,933 -6.8% 0% $32,007,956
Boston Trust Walden Corp 0.73% 449,530 -49% 0.22% $26,998,771
MILLENNIUM MANAGEMENT LLC 0.7% 429,592 -11% 0.02% $25,801,296
BANK OF AMERICA CORP /DE/ 0.7% 426,024 -6.7% 0% $25,587,002
Grantham, Mayo, Van Otterloo & Co. LLC 0.66% 402,912 +1.4% 0.06% $24,198,895
D. E. Shaw & Co., Inc. 0.64% 391,966 -2.4% 0.02% $23,541,478
LAZARD ASSET MANAGEMENT LLC 0.63% 387,100 -6.7% 0.04% $23,249,226

Institutional Holders of Dolby Laboratories, Inc. - Class A Common Stock (DLB) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q1 58,387,638 $3,505,571,671 -$49,940,846 $60.06 411
2025 Q4 58,614,717 $3,767,152,036 +$98,976,962 $64.22 401
2025 Q3 57,079,742 $4,132,169,589 -$64,318,369 $72.37 409
2025 Q2 57,910,897 $4,300,919,736 +$135,367,374 $74.26 403
2025 Q1 56,076,827 $4,502,243,319 +$66,643,726 $80.31 416
2024 Q4 55,348,515 $4,323,056,016 +$57,055,250 $78.10 415
2024 Q3 54,507,323 $4,169,262,179 -$9,872,765 $76.53 407
2024 Q2 54,615,449 $4,327,588,819 -$58,687,750 $79.23 427
2024 Q1 55,482,471 $4,648,008,511 -$59,544,827 $83.77 411
2023 Q4 56,186,063 $4,842,108,955 -$145,683,431 $86.18 425
2023 Q3 57,733,894 $4,575,878,313 +$240,780,701 $79.26 408
2023 Q2 54,630,261 $4,571,642,294 +$13,689,177 $83.68 412
2023 Q1 54,134,708 $4,623,220,063 -$48,099,771 $85.42 407
2022 Q4 56,276,748 $3,969,535,751 +$256,026,424 $70.54 385
2022 Q3 56,087,489 $3,651,409,552 -$244,417,512 $65.15 362
2022 Q2 59,311,811 $4,248,208,097 -$100,287,581 $71.56 350
2022 Q1 61,084,825 $4,777,011,387 +$30,841,883 $78.22 344
2021 Q4 60,326,889 $5,742,845,171 +$65,560,052 $95.22 361
2021 Q3 59,655,172 $5,252,006,960 -$147,200,196 $88.00 369
2021 Q2 60,674,874 $5,964,343,589 -$32,865,018 $98.29 370
2021 Q1 61,354,058 $6,057,461,576 -$37,978,425 $98.72 364
2020 Q4 61,450,884 $5,968,271,661 +$87,787,735 $97.13 333
2020 Q3 59,533,303 $3,944,477,356 -$33,412,670 $66.28 323
2020 Q2 59,889,877 $3,943,162,300 +$28,340,058 $65.87 300
2020 Q1 59,846,478 $3,243,990,790 +$18,349,522 $54.21 296
2019 Q4 58,753,443 $4,045,257,248 -$2,505,354 $68.80 315
2019 Q3 58,781,361 $3,798,483,313 +$31,256,436 $64.64 291
2019 Q2 58,297,819 $3,766,191,539 +$135,364,971 $64.60 298
2019 Q1 57,666,973 $3,633,142,953 -$17,512,286 $62.97 313
2018 Q4 57,901,645 $3,580,411,432 -$58,188,711 $61.84 301
2018 Q3 58,837,851 $4,116,833,571 -$19,383,805 $69.97 302
2018 Q2 59,152,943 $3,649,248,032 +$113,748,037 $61.69 269
2018 Q1 57,237,301 $3,637,817,738 +$135,785,122 $63.56 283
2017 Q4 55,145,723 $3,418,853,410 +$29,186,299 $62.00 276
2017 Q3 54,580,794 $3,139,579,375 +$114,684,815 $57.52 241
2017 Q2 52,855,447 $2,587,932,363 +$29,865,405 $48.96 253
2017 Q1 52,267,416 $2,739,265,702 +$127,759,786 $52.41 240
2016 Q4 52,185,723 $2,358,873,878 -$60,248,161 $45.19 271
2016 Q3 52,960,918 $2,873,204,449 +$132,978,471 $54.29 243
2016 Q2 50,654,839 $2,423,836,084 +$28,931,477 $47.85 232
2016 Q1 50,885,019 $2,211,354,029 +$106,946,639 $43.46 200
2015 Q4 49,082,436 $1,652,010,748 +$72,023,358 $33.65 198
2015 Q3 46,705,898 $1,522,598,234 -$30,878,300 $32.60 194
2015 Q2 48,121,889 $1,909,434,162 +$70,321,542 $39.68 196
2015 Q1 46,408,790 $1,771,263,677 -$12,840,346 $38.16 204
2014 Q4 46,749,511 $2,015,065,266 -$91,011,298 $43.12 197
2014 Q3 48,036,217 $2,007,413,864 +$1,247,952 $41.79 202
2014 Q2 47,942,559 $2,071,115,430 -$104,427,355 $43.20 196
2014 Q1 50,281,703 $2,237,287,676 +$41,824,612 $44.50 184
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .